ArticleCancer medicine2023

Anaemia and pathologic complete response rate according to carboplatin dose in HER2+ breast cancer treated with neoadjuvant TCHP.

Jung Hwan Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.